ARMISTICE CAPITAL, LLC enters SEELOS THERAPEUTICS, INC. with 13.80M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Indirect Derivatives

ARMISTICE CAPITAL, LLC

Filed: 9/27/2018ACC: 0000919574-18-006350

InsiderARMISTICE CAPITAL, LLCCIK 1601086

→

IssuerSEELOS THERAPEUTICS, INC.CIK 1017491

10% Owner

Since Sep 2018

13.80M

Baseline shares

33% direct

4.60M

Direct ownership

1 position

18.38M

Derivative underlying

6 instruments

Security positions

9.20M indirect

Non-Derivative Holdings3

Common Stock, par value $.001

Indirect

Shares owned4.60M

Common Stock, par value $.001

Direct

Shares owned4.60M

Common Stock, par value $.001

Indirect

Shares owned4.60M

Total

4.60M direct·9.20M indirect13.80M

Security Title	Shares Owned	Ownership Type
Common Stock, par value $.001	4.60M	Indirect
Common Stock, par value $.001	4.60M	Direct
Common Stock, par value $.001	4.60M	Indirect
Total	13.80M	4.60M direct·9.20M indirect

Derivative Holdings6

Warrants

Indirect

Underlying security

Common Stock

Underlying shares

2.68M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Warrants

Indirect

Underlying security

Common Stock

Underlying shares

3.45M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Warrants

Direct

Underlying security

Common Stock

Underlying shares

2.68M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Warrants

Direct

Underlying security

Common Stock

Underlying shares

3.45M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Warrants

Indirect

Underlying security

Common Stock

Underlying shares

2.68M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Warrants

Indirect

Underlying security

Common Stock

Underlying shares

3.45M

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Total

Underlying

18.38M

Owned

0.00

Security	Underlying	Exercise Window	Expiration	Underlying Shares	Shares Owned
Warrants Indirect	Common Stock	—	—	2.68M	N/A
Warrants Indirect	Common Stock	—	—	3.45M	N/A
Warrants Direct	Common Stock	—	—	2.68M	N/A
Warrants Direct	Common Stock	—	—	3.45M	N/A
Warrants Indirect	Common Stock	—	—	2.68M	N/A
Warrants Indirect	Common Stock	—	—	3.45M	N/A
Total				18.38M	0.00